Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 1008

Sort by

Sort Order Select

Journal Articles

A minority of T cells recognizing tumor-associated antigens presented in self-HLA can provoke antitumor reactivity

Marthe C. J. Roex, Lois Hageman, Sabrina A. J. Veld, Esther van Egmond, Conny Hoogstraten, Christian Stemberger, Lothar Germeroth, Hermann Einsele, J. H. Frederik Falkenburg, Inge Jedema

Blood (2020) 136 (4): 455–467.

https://doi.org/10.1182/blood.2019004443

Published: 2020

Includes: Supplemental data

Journal Articles

HLA-B leader and survivorship after HLA-mismatched unrelated donor transplantation

Effie W. Petersdorf, Philip Stevenson, Mats Bengtsson, Dianne De Santis, Valerie Dubois, Ted Gooley, Mary Horowitz, Katharine Hsu, J. Alejandro Madrigal, Mari Malkki, Caroline McKallor, Yasuo Morishima, Machteld Oudshoorn, Stephen R. Spellman, Jean Villard, Mary Carrington

Blood (2020) 136 (3): 362–369.

https://doi.org/10.1182/blood.2020005743

Published: 2020

Includes: Supplemental data

Journal Articles

Impact of Human Leukocyte Antigen on the Risk of Stroke in Patients with Sickle Cell Disease

Huda Al-Harrasi, MD, Murtadha Al-Khabori, MD, Salam Al-Kindi, MD, Yasser Ahmed Mohamed Soliman Wali, MD, Mohamed Al Huneini, MD, Hamad Al-Riyami, PhD

Blood (2019) 134 (Supplement_1): 4831.

https://doi.org/10.1182/blood-2019-125038

Published: 2019

Journal Articles

Less Chronic Graft-Versus-Host Disease, Immunosuppressive Therapy and Better Survival after Anti-Thymocyte Globulin in Unrelated Donor Stem Cell Transplant Recipients: Longer Follow-up of a Multicentre Cell Therapy Transplant Canada Randomized Trial

Jean Roy, MD, Tony Panzarella, M.Sc., P.Stat, Stephen Couban, MDBSc, Félix Couture, MD FRCPC, Gerald M. Devins, PhD, Mohamed Elemary, MD, Stephen Ronan Foley, MD FRCPC, Genevieve Gallagher, MD, John Kuruvilla, MD, Stephanie J. Lee, MD MPH, John Moore, MDFRACP,FRCPA, Thomas J Nevill, MD, Gizelle Popradi, MD FRCP, Kirk R. Schultz, MD, David Szwajcer, MD FRCPC, Cynthia L Toze, MD FRCPC, Irwin Walker, MBBS, FRCPC

Blood (2019) 134 (Supplement_1): 875.

https://doi.org/10.1182/blood-2019-123275

Published: 2019

Journal Articles

Clonal Hematopoiesis and Genetic Mutations in Individual Patients with Acquired Bone Marrow Failure Diseases

Baixin Ye, Xinhua Du, Li Yan, Qingping Gao, Chunrui Li, MD PhD, Jianfeng Zhou, Xin Yi, Fankai Meng

Blood (2019) 134 (Supplement_1): 937.

https://doi.org/10.1182/blood-2019-125357

Published: 2019

Journal Articles

Post-Transplant Cyclophosphamide Improved Outcomes of HLA Mismatched Hematopoietic Stem Cell Transplantation in Children with β-Thalassemia Major

Jianyun Wen, Yuelin He, MD, Xiaoxiao Xu, Libai Chen, MD, Xuedong Wu, MD PhD, Xiaoqin Feng, Chunfu Li, Xuan Liu, Fuyu Pei

Blood (2019) 134 (Supplement_1): 801.

https://doi.org/10.1182/blood-2019-130038

Published: 2019

Journal Articles

Preclinical Validation of Alpha-Enolase (ENO1) As a Novel Immunometabolic Target in Multiple Myeloma

Arghya Ray, PhD, Yan Song, PhD, Dharminder Chauhan, PhD, Kenneth C. Anderson, MD

Blood (2019) 134 (Supplement_1): 856.

https://doi.org/10.1182/blood-2019-123328

Published: 2019

Journal Articles

Mutational Dynamics and Evolutionary Divergence in DLBCL: A Call for Relapse Sampling

Blood (2019) 134 (Supplement_1): 1497.

https://doi.org/10.1182/blood-2019-131072

Published: 2019

Journal Articles

Human Leukocyte Antigen Matched Unrelated Donors for Patients with Sickle Cell Disease According to Geographic Origin: Results of International Donor Searches

Blood (2019) 134 (Supplement_1): 1021.

https://doi.org/10.1182/blood-2019-124592

Published: 2019

Journal Articles

A Common HLA Allelic Mutation of exon1 in Leukocytes Defines Class I Alleles Responsible for Autoantigen Presentation of Acquired Aplastic Anemia

Hiroki Mizumaki, MD, Kazuyoshi Hosomichi, PhD, Tatsuya Imi, MD PhD, Noriaki Tsuji, MD, Tanabe Mikoto, MD, Dung Cao Tran, MD, Kohei Thi Hosokawa, MD PhD, Yoshitaka Zaimoku, MD PhD, Kohei Hosokawa, MD PhD, Takamasa Katagiri, PhD, Fumihiro Azuma, Atsushi Tajima, PhD, Shinji Nakao, MD PhD

Blood (2019) 134 (Supplement_1): 1215.

https://doi.org/10.1182/blood-2019-123266

Published: 2019

Journal Articles

Distinct Escape Mechanisms of HLA Class I Allele-Lacking Hematopoietic Stem Progenitor Cells (HSPCs) from GPI-Deficient HSPCs in Acquired Aplastic Anemia

Noriaki Tsuji, MD, Kohei Hosokawa, MD PhD, Takeshi Yoroidaka, MD, Tanabe Mikoto, MD, Hiroki Mizumaki, MD, Shinji Nakao, MD PhD

Blood (2019) 134 (Supplement_1): 1216.

https://doi.org/10.1182/blood-2019-122798

Published: 2019

Journal Articles

Novel HLA Typing Method Identifies HLA Alleles Associated with Pediatric ITP

Taylor Olmsted Kim, MD, Michael Greenwood, MD, Todd Eagar, PhD, Jenny M. Despotovic, DO, MS

Blood (2019) 134 (Supplement_1): 1067.

https://doi.org/10.1182/blood-2019-129235

Published: 2019

Journal Articles

Repertoire of Cytomegalovirus-Specific T Cells Is Focused on the Immunodominant Epitopes in Fixed Hierarchy Dependent on HLA Genotype of the Donor

Alexandra Vladimirovna Maleeva, MSc, Vyacheslav Anatolevich Shmarov, Dmitry Olegovych Kiryukhin, Grigory Aleksandrovich Efimov, MD PhD, Valery G. Savchenko, MD PhD academician

Blood (2019) 134 (Supplement_1): 2327.

https://doi.org/10.1182/blood-2019-130241

Published: 2019

Journal Articles

Somatic Mutations and Loss of Heterozygosity of HLA Genes Are Frequently Occurred and Tightly Associated with Poor Prognosis in Adult T Cell Leukemia-Lymphoma

Keita Tamaki, MD, Satoko Morishima, MD PhD, Shingo Suzuki, PhD, Atsuko Shigenari, Ikumi Nomura, Yutaro Yokota, Kazuho Morichika, MD, Yukiko Nishi, MD PhD, Sawako Nakachi, MD PhD, Shiki Okamoto, PhD, Kennosuke Karube, MD PhD, Takuya Fukushima, MD PhD, Takashi Shiina, PhD, Hiroaki Masuzaki, MD PhD

Blood (2019) 134 (Supplement_1): 2785.

https://doi.org/10.1182/blood-2019-128070

Published: 2019

Journal Articles

HLA Alleles Repertoire in Russian CLL Patients

Bella V. Biderman, PhD, Ekaterina G Khamaganova, PhD DSc, Ekaterina B Likold, Alena R Abdrakhimova, Evgeny A Leonov, Andrey B Sudarikov, PhDDSc, Valery G. Savchenko, MD PhD academician

Blood (2019) 134 (Supplement_1): 5462.

https://doi.org/10.1182/blood-2019-123649

Published: 2019

Journal Articles

Identification and Characterization of CMV-Specific, HLA-C*07:02 Restricted Antibodies

Moritz Bewarder, MD, Gerhard Held, MD, Lorenz Thurner, MD, Klaus Dieter Preuss, PhD, Gabi Carbon, Birgit Bette, Konstantinos Christofyllakis, MD, Arne Felbel, Dominic Kaddu-Mulindwa, MD, Niels Murawski, MD, Stephan Stilgenbauer, Frank Neumann, PhD

Blood (2019) 134 (Supplement_1): 5616.

https://doi.org/10.1182/blood-2019-126998

Published: 2019

Journal Articles

Development of an Immunotherapeutic Monoclonal Antibody Recognizing DKK1-HLA-A2 Complex to Treat Human Hematologic Malignancies

Jianfei Qian, PhD, Qiang Wang, PhD, Lintao Liu, PhD, Enguang Bi, PhD, Xingzhe Ma, PhD, Pan Su, PhD, Maojie Yang, Qing Yi, MD PhD

Blood (2019) 134 (Supplement_1): 5551.

https://doi.org/10.1182/blood-2019-123541

Published: 2019

Journal Articles

Deep Profiling of Genetic Aberrations and Clonal Evolution in Follicular Lymphoma

Baoyan Bai, PhD, Daniel Vodák, BS, Sigve Nakken, PhD, Jillian F. Wise, PhD, Yngvild Nuvin Blaker, MD PhD, Ole Christian Lingjærde, PhD, Marianne Brodtkorb, MD PhD, Vera Hilden, Gunhild Trøen, Suzanne Lorenz, PhD, Michael S. Lawrence, PhD, Ola Myklebost, PhD, Leonardo Meza-Zepeda, PhD, Klaus Beiske, MD PhD, Eivind Hovig, PhD, Erlend B. Smeland, MD PhD, Harald Holte, MD PhD, June Helen Myklebust, PhD

Blood (2019) 134 (Supplement_1): 20.

https://doi.org/10.1182/blood-2019-128403

Published: 2019

Journal Articles

First-in-Human Assessment of Feasibility and Safety of Multiplexed Genetic Engineering of Autologous T Cells Expressing NY-ESO -1 TCR and CRISPR/Cas9 Gene Edited to Eliminate Endogenous TCR and PD-1 (NYCE T cells) in Advanced Multiple Myeloma (MM) and Sarcoma

Blood (2019) 134 (Supplement_1): 49.

https://doi.org/10.1182/blood-2019-122374

Published: 2019

Journal Articles

Impact of Donor KIR and HLA Genotypes on Clinical Outcomes According to Pre-Transplant Remission Status after HLA-Haploidentical Transplantation with Post-Transplantation Cyclophosphamide

Kentaro Ido, MD, Hideo Koh, MD PhD, Hiroshi Okamura, MD PhD, Shiro Koh, MD PhD, Satoru Nanno, MD PhD, Mitsutaka Nishimoto, MD PhD, Asao Hirose, MD PhD, Mika Nakamae, MD PhD, Yasuhiro Nakashima, MD PhD, Takahiko Nakane, MD PhD, Masayuki Hino, MD PhD, Hirohisa Nakamae, MD PhD

Blood (2019) 134 (Supplement_1): 2030.

https://doi.org/10.1182/blood-2019-125173

Published: 2019

NARROW

A minority of T cells recognizing tumor-associated antigens presented in self-HLA can provoke antitumor reactivity

HLA-B leader and survivorship after HLA-mismatched unrelated donor transplantation

Impact of Human Leukocyte Antigen on the Risk of Stroke in Patients with Sickle Cell Disease

Less Chronic Graft-Versus-Host Disease, Immunosuppressive Therapy and Better Survival after Anti-Thymocyte Globulin in Unrelated Donor Stem Cell Transplant Recipients: Longer Follow-up of a Multicentre Cell Therapy Transplant Canada Randomized Trial

Clonal Hematopoiesis and Genetic Mutations in Individual Patients with Acquired Bone Marrow Failure Diseases

Post-Transplant Cyclophosphamide Improved Outcomes of HLA Mismatched Hematopoietic Stem Cell Transplantation in Children with β-Thalassemia Major

Preclinical Validation of Alpha-Enolase (ENO1) As a Novel Immunometabolic Target in Multiple Myeloma

Mutational Dynamics and Evolutionary Divergence in DLBCL: A Call for Relapse Sampling

Human Leukocyte Antigen Matched Unrelated Donors for Patients with Sickle Cell Disease According to Geographic Origin: Results of International Donor Searches

A Common HLA Allelic Mutation of exon1 in Leukocytes Defines Class I Alleles Responsible for Autoantigen Presentation of Acquired Aplastic Anemia

Distinct Escape Mechanisms of HLA Class I Allele-Lacking Hematopoietic Stem Progenitor Cells (HSPCs) from GPI-Deficient HSPCs in Acquired Aplastic Anemia

Novel HLA Typing Method Identifies HLA Alleles Associated with Pediatric ITP

Repertoire of Cytomegalovirus-Specific T Cells Is Focused on the Immunodominant Epitopes in Fixed Hierarchy Dependent on HLA Genotype of the Donor

Somatic Mutations and Loss of Heterozygosity of HLA Genes Are Frequently Occurred and Tightly Associated with Poor Prognosis in Adult T Cell Leukemia-Lymphoma

HLA Alleles Repertoire in Russian CLL Patients

Identification and Characterization of CMV-Specific, HLA-C*07:02 Restricted Antibodies

Development of an Immunotherapeutic Monoclonal Antibody Recognizing DKK1-HLA-A2 Complex to Treat Human Hematologic Malignancies

Deep Profiling of Genetic Aberrations and Clonal Evolution in Follicular Lymphoma

First-in-Human Assessment of Feasibility and Safety of Multiplexed Genetic Engineering of Autologous T Cells Expressing NY-ESO -1 TCR and CRISPR/Cas9 Gene Edited to Eliminate Endogenous TCR and PD-1 (NYCE T cells) in Advanced Multiple Myeloma (MM) and Sarcoma

Impact of Donor KIR and HLA Genotypes on Clinical Outcomes According to Pre-Transplant Remission Status after HLA-Haploidentical Transplantation with Post-Transplantation Cyclophosphamide

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only